Asthma, allergic rhinitis and atopic dermatitis are multifactorial disorders influenced by various familial and environmental factors. Cord blood IgE levels may be predictive for subsequent allergy onset. Serum IgE assessment has been rarely investigated. This study is aimed at evaluating serum IgE levels during the first year of life and relating to subsequent allergies. Total serum IgE levels were assessed in 102 newborns in the first days of life (2) (3) and then again at 3, 5, 6, 11 and 12 months of age. After ten years, paediatricians and general practitioners caring for these children were tracked through the Local Healthcare Agency (LHA) database and asked about possible allergy of their patients, including transient ones. F Serum IgE increased in allergic infants at 1 year oflife. The predictive model was significant. In conclusion, this study demonstrates that serum IgE may be predictive of subsequent allergy onset, preferably if assessed at 1 year of age.
Total serum immunoglobulin E (IgE) levels are frequently, but not always, elevated in patients with allergic disease and may be increased in many other disorders (1). Asthma, allergic rhinitis, and atopic dermatitis are multifactorial allergic diseases, as influenced by various familial and environmental factors. Distinct fetal and perinatal exposures may have an effect on cord blood lympho-proliferative responses. The implication of these findings on the future development of allergy or asthma are, as yet, unknown.
It has been previously indicated that high cord total IgE and familiarity in newborns may represent a risk factor for future allergy development. Indeed, when total IgE levels are elevated in cord blood (> 0.9 KU/L), an increased risk in the development of atopic diseases has been demonstrated (2), and high cord blood IgE is significantly associated with the 16132 Genoa, Italy Tel: ++391035331820 Fax: ++39 10 3538664 e-mail: gio.cip@libero.it genetic polymorphism IL-4-590C7T, but not with the genotypes FceRlp, LT-a and TNF-a (3). Cord blood IgE evaluation is a simple, non-invasive and convenient test which can supplement the parental history and provide more discriminative information on the allergic status of the newborn (4) .
The relationship between serum IgE levels at birth and total IgE of the mother is controversial. Some authors did not find any correlation between serum IgE in mothers and their newborns (5) or in the respective cord blood (6), while others found that cord blood IgE is significantly higher when maternal IgE is over 100 KU/L (7) . A recent study evidenced that total serum IgE levels in infants of mothers who presented serum IgE levels> 100 kU/L exceed the norm during the first year of life, even though still in the absence of overt allergic disease (8) . Moreover, Lilja et al. reported that paternal heredity has no significant influence on infant IgE, in contrast there is a strong maternal hereditary influence (9) .
Two longitudinal studies showed a correlation between cord serum IgE and development of allergic symptoms and sensitization (10) (11) . The aim of this study is to measure multiple measurements of total serum IgE in the first year of life and to correlate it with occurrence of allergic diseases in childhood till the age of 10 years. a complex. After incubation, unbound enzyme-anti-IgE is washed away and the bound complex is then incubated with a developing agent. After stopping the reaction, the fluorescence of the eluate is measured. The fluorescence is directly proportional with the concentration of IgE in the sample. To evaluate the test results, the response for the patient samples is compared directly to the response for the calibrators.
Statistical analysis
Descriptive statistics were first performed and quantitative parameters were reported as medians (md) with first and third quartiles (IQ) due to the skewed distribution. The non-parametric Wilcoxon test was performed to evaluate the IgE differences between allergic/non-allergic subjects. All tests were two-sided and a p-value less than 0.05 was considered statistically significant. The package "S-Plus" (MathSoft Corp.) was used for all the analyses.
RESULTS
Children were divided into two groups (allergic, n=44, 47%; not allergic, n=50, 53%), according to the information obtained from physicians. Allergic children were divided into three groups: i) children Ip=O. OOO3 I
MATERIALS AND METHODS

Patients and study design
Total serum IgE of 102 newborns (50 females, 52 males) and their mothers were collected during the first year of life (newborn and mother at the delivery, newborn only at 3, 5, 6, II, 12 months) in 1999. No infants had any allergic manifestation during the first year oflife. After ten years, paediatricians and general practitioners caring for these children were tracked through the Local Healthcare Agency (LHA) database and asked about possible allergy of their patients, including transient ones. Ninety-four children could be evaluated.
Non.allergic
Allergic
Total serum 19E analysis
Total serum IgE (12) was measured by a fluorescent immunoassay (FEIA, Phadia) according to the manufacturer's instructions, and for infants a low-range anti-IgE antibody was employed. Anti-IgE, covalently coupled to ImmunoCAP reaction vessel, reacts with the total IgE in the patient specimen. After washing, enzyme-labelled antibodies against IgE are added to form with respiratory allergy (n=3l), ii) children with cutaneous allergy (n= 11), and iii) children with both cutaneous and respiratory allergy (n=2). The curves obtained fitting IgE values on the different times for the two groups (Fig. I) show that, on average, allergic subjects always have higher values, even if significant differences were only found at 6 and 12 months. More precisely, we found p=0.02 for newborn IgE at 6 months (not allergic: md 3.53 kU/L, 1Q 1.81-13.9; allergic: md 9.01 kU/L, IQ 5.6-16.5) and p<O.OI at 12 months (not allergic: md 13.6 kU/L, IQ 7.34-38.05; allergic: md 27.9 kU/L, IQ 19.5-69.4), (see Fig. 2 ). At 11 months, we found the same trend (not allergic: md 5.6 kU/L, lQ 4.26-20.6; allergic: md 13 kU/L, IQ 4-27.9), even if not statistically significant: probably, this could be explained by the lower number of samples available at this time (not all the children had the full set of samples). Moreover, as a global index, we have calculated the areas under the above-mentioned 19E curves (AUC) for each child: difference between allergic and not allergic children was significant (not allergic AUC: md 48.9, IQ 25.7-125.1; allergic AUC: md 106.9, IQ 48.6-219.7; p=0.028).
DISCUSSION
This study confirms the correlation between high serum total IgE values and further clinical allergy development. Most of the previous studies were conducted measuring cord blood IgE, while the present study exploits serum total IgE levels. Interestingly, it has been found that newborn's levels at birth are not predictive for future allergy, while summing up newborn's and mother's levels significant predictions have been obtained, thuc onfirming the cord blood IgE studies. Therefore, since cord evaluation is not always available, the present study may suggest that total serum IgE assessment may be an appropriate alternative.
The present study also shows the importance of subsequent measures during the first year of life. In fact, while at delivery the newborn 's IgE alone are not predictive (as discussed above), later measurements, namely at the 6th and 12th months, may become predictive for further allergy development.
Nevertheless, this study has some limitations: clinical data derived from family paediatricians' files that may be vague, the cohort was limited, the measurement times were restricted to the first year. In conclusion, this study demonstrates that serum total IgE may be predictive of subsequent allergy onset, preferably if summed up to that of the mother at birth or assessed after 6 months of age in the newborn,
